To better understand how GR activity relates to luminal breast cancer phenotypes, we performed a PAM50‐based principal component analysis (PCA) of the gene expression TCGA data, focusing on luminal cancers, projecting the GRa scores on top (Fig 2F). This evidence concerns the gene NR3C1 and breast cancer.